Top Markets
#1 Black Phoenix Black Phoenix +357.72%
#2 Islamic Coin Islamic Coin +158.16%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.42%
#6 Palladium Network Palladium Network +7.87%
#7 Pons Pons +7.21%
#8 Victoria VR Victoria VR +5.38%
#9 Movement Movement +5.24%
#10 Espresso Espresso +4.91%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Rangering i aksjer #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Aksjekurs
$0.85
Sist synkronisert: 2025-01-21
Markedsverdi
$411.40
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Fresh2 Group Limited (FRES)

Kategori

Healthcare
Inntekter for Fresh2 Group Limited (FRES)
Inntekter i Jun 2023 TTM: $-13.66M
Ifølge Fresh2 Group Limited sine nyeste økonomiske rapporter er selskapets nåværende resultat $-13.66M. I 2021 hadde selskapet et resultat på $-18.85M, en nedgang sammenlignet med resultatet i 2020, som var $-11.67M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Fresh2 Group Limited fra 2017 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-13.66M -10.89%
2022 $-15.33M -18.70%
2021 $-18.85M 61.55%
2020 $-11.67M -20.14%
2019 $-14.61M 130.04%
2018 $-6.35M 7.85%
2017 $-5.89M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -38,721.23%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -14,382.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -22,106.96%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR